INO INOVIO PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2024 - Stock Offering Inovio Pharmaceuticals has entered into an agreement to potentially sell up to $60 million of its common stock through Oppenheimer & Co. Inc., with the sales agent earning a commission of up to 3% on sales.Get access to all SEC 8-K filings of the INOVIO PHARMACEUTICALS INC